|
|
NEWS
Nuvera founder, Dr. Christos Hatzis, to discuss methods for predicting therapy response at Personalized Medicine conference
Woburn, MA - October 14, 2009.
Nuvera Biosciences founder, Dr. Christos Hatzis, has been invited to present at the Personalized Medicine Symposium being held at Penn State University on October 29, 2009. Dr. Hatzis will discuss the topic, "Residual Cancer Burden to Accurately Monitor and Identify Biomarkers for Response." The conference will be held at the Hospital Auditorium, Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania. The conference which will focus on two themes, Predictors of Response and Resistance to Targeted Agents, will also include presentations from leading molecular oncology researchers, physicians and pathologists.
|
|
|
|
